PHASE-III TRIAL WITH OR WITHOUT GM-CSF ADMINISTERED BEFORE AND DURINGHIGH-DOSE CYTARABINE IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA - CALGB-9021
Ba. Peterson et al., PHASE-III TRIAL WITH OR WITHOUT GM-CSF ADMINISTERED BEFORE AND DURINGHIGH-DOSE CYTARABINE IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA - CALGB-9021, Journal of clinical oncology, 14(5), 1996, pp. 2016-2016